Changhua

5 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	NCT ID
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis	MASH With Fibrosis; NASH With Fibrosis	Recruiting	Phase 3	2026-10-06	NCT06215716
Electroacupuncture and Exercise for Chemotherapy-Induced Peripheral Neuropathy (CIPN)	cancer, neoplasm	Recruiting	Not applicable	2026-08-28	NCT07700901
Self-Management Support for Lung Cancer Patients With Cachexia	Neoplasms by Site, Thoracic Neoplasms, lung disorder, lung neoplasm, neoplasm, respiratory system disorder, respiratory tract neoplasm	Active, not recruiting	Not applicable	2026-05-13	NCT05731076
A Study Evaluating Efruxifermin in Subjects With Non-invasively Diagnosed Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Nonalcoholic Fatty Liver Disease (NAFLD)/Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)	Digestive System Diseases, fatty liver disease, liver disorder, metabolic dysfunction-associated steatotic liver disease	Active, not recruiting	Phase 3	2026-04-30	NCT06161571
Transcutaneous Electrical Acupoint Stimulation on Symptoms Associated with Chemotherapy Induced Peripheral Neuropathy	Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder	Recruiting	Not applicable	2024-11-06	NCT05904340

Clinical trials